San Francisco, CA, United States of America

Nicholas Marini

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Nicholas Marini in Biochemical Pathways

Introduction

Nicholas Marini is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of biochemistry, particularly in the identification of inhibitors of isoprenoid metabolic pathways. His work has implications for therapeutic targets in various biological pathways.

Latest Patents

Nicholas Marini holds a patent titled "Methods for the identification of inhibitors of an isoprenoid metabolic pathway." This invention relates to methods for identifying genes whose expression indicates the activation of specific biochemical or metabolic pathways. The patent also discusses methods for partially characterizing genes of unknown function by associating their expression with biological pathways, thereby categorizing them within functional genetic groups known as 'regulons.' Furthermore, the invention provides methods for identifying effectors of regulon target genes, including examples of inhibitors.

Career Highlights

Nicholas Marini is currently associated with Rosetta Inpharmatics, Inc., where he continues to advance research in metabolic pathways. His innovative approaches have positioned him as a key figure in the field of biochemistry.

Collaborations

Some of his notable coworkers include Matthew N Ashby and Stewart Scherer, who have collaborated with him on various projects related to his research.

Conclusion

Nicholas Marini's work in identifying inhibitors of isoprenoid metabolic pathways showcases his innovative spirit and dedication to advancing biochemistry. His contributions are paving the way for future therapeutic developments in this critical area of research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…